Valuation : Navamedic ASA

Market Cap 332M 35.8M 30.87M 29.2M 26.48M 49.32M 3.42B 49.92M 346M 133M 1.74B 134M 131M 5.46B P/E 2026 *
-51.6x
P/E 2027 * 44.3x
Enterprise Value 452M 48.69M 41.97M 39.7M 36.01M 67.07M 4.65B 67.88M 471M 181M 2.36B 183M 179M 7.43B EV / Sales 2026 *
0.79x
EV / Sales 2027 * 0.71x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.84%
Current month-2.12%
1 month-18.53%
3 months-18.05%
6 months-31.77%
Current year-41.81%
1 week 13.25
Extreme 13.25
13.95
1 month 13.25
Extreme 13.25
17.95
Current year 13.25
Extreme 13.25
24.5
1 year 13.25
Extreme 13.25
26.5
3 years 13.25
Extreme 13.25
43.9
5 years 13.25
Extreme 13.25
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 55 2026-06-17
Director of Finance/CFO - 2025-12-31
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 2022-05-31
Director/Board Member - 2023-05-31
Director/Board Member 60 2024-05-31
Date Insider Type Main position Quantity % Market Cap. Importance
12/19/24 Buy

Chief Operating Officer

10,267 0.0581%
9/9/24 Exercice

Chief Executive Officer

80,000 0.4589%
9/9/24 Exercice

Chief Operating Officer

75,000 0.4302%
Change 5-day change 1-year change 3-year change Capi.($)
+1.84%0.00%-35.58%-56.72% 35.76M
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-2.07%+11.48% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.08%-59.58% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.47%-5.18%+16.23%+30.82% 350.48B
Weighted average by Cap. -0.51%-4.42%+30.89%+55.07%

Financials

2026 *2027 *
Net sales 570M 61.43M 52.96M 50.09M 45.43M 84.62M 5.87B 85.64M 594M 229M 2.98B 231M 226M 9.37B 604M 65.1M 56.13M 53.09M 48.15M 89.69M 6.22B 90.77M 630M 243M 3.16B 244M 239M 9.93B
Net income -6.5M -700K -604K -571K -518K -965K -66.9M -976K -6.77M -2.61M -34M -2.63M -2.57M -107M 7.7M 830K 715K 677K 614K 1.14M 79.28M 1.16M 8.03M 3.09M 40.29M 3.12M 3.05M 127M
Net Debt 120M 12.88M 11.11M 10.5M 9.53M 17.75M 1.23B 17.96M 125M 47.99M 626M 48.38M 47.31M 1.97B 96.9M 10.45M 9.01M 8.52M 7.73M 14.39M 998M 14.56M 101M 38.92M 507M 39.23M 38.36M 1.59B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
26-09-11 NOK 13.85 +1.84% 47,585
26-09-10 NOK 13.60 +0.37% 59,681
26-09-09 NOK 13.55 +0.37% 58,343
26-09-08 NOK 13.50 -1.46% 62,787
26-09-07 NOK 13.70 -1.08% 67,116
Trader
-
Investor
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.85NOK
Average target price
21.00NOK
Spread / Average Target
+51.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!